Medicaid Advisory Committee
September 23, 2015
General Services Building Salem, Oregon
Medicaid Advisory Committee September 23, 2015 General Services - - PowerPoint PPT Presentation
Medicaid Advisory Committee September 23, 2015 General Services Building Salem, Oregon Time Item Presenter 9:00 Opening Remarks Co-Chairs Oregon Health Plan (OHP) and Coordinated Care Organizations OHA update Rhonda Busek, Janna Starr, 9:05
General Services Building Salem, Oregon
Time Item Presenter 9:00 Opening Remarks Co-Chairs 9:05 Oregon Health Plan (OHP) and Coordinated Care Organizations – OHA update OHP enrollment and determination dashboard OHP quarterly report; 2nd quarter 2015 Rhonda Busek, Janna Starr, OHA 9:25 Oral Health and OHP – OHA Dental Director Oral health and OHP 2015 legislative priorities and OHA initiatives on oral health
9:55 InterCommunity Health Network CCO Community Advisory Council (CAC)
activities
in the CHIP Rebekah Fowler, CAC Coordinator 10:25 Break 10:30 Medicaid 12 Month Continuous Eligibility
Co-Chairs; staff 11:20 Health Evidence Review Commission (HERC) Darren Coffman, Jason Gingerich, OHA 11:50 Closing comments Co-Chairs
Rhonda Busek and Janna Starr Health Systems Division, OHA
Bruce Austin, OHA Dental Director
CAC Coordinator
54
Problem: Low and moderate-income parents and childless adults experience substantial income volatility throughout the year, which affects eligibility and can cause churning on and off Medicaid – Option for children since 1997; 32 states have adopted policy in their Medicaid or CHIP programs; 23 states have in both programs – Federal policy has been an option for Medicaid adults since 2013
for their adult populations, likely due to financing barriers Impact: Promotes coverage continuity for eligible individuals, despite fluctuations in income or other eligibility criteria, but also creates additional costs for a state Policy: 12-Month Continuous Eligibility Allows beneficiaries to maintain coverage for up to one full year, even if individuals/families experience a change in income or family status
Forecast OHP enrollment for 17-19 biennium Develop continuity
ratios Estimate annual program expenditures for 17-19 biennium Calculate federal/state program costs for current and new eligibility policy Estimate budget impact for 12- month continuous eligibility for income-eligible OHP adults
researchers at George Washington University (GWU) in 2009
18
Eligibility Categories Current Policy (%) New Policy (%) Difference Medicaid Expansion Adults 68.2 78.7 +10.5 Aid to the Blind and Aid to the Disabled (AB/AD) 83.8 87.3 +3.5 Parent/Caretaker Relative 61.9 77.7 +15.8
Sources: George Washington’s analysis of Medicaid Statistical Information System Datamart for FY 2006-11; DHS/OHA Integrated Client Services data warehouse, 2008-2012
Table 2. Continuity Ratios, 2017-19 Biennium 100% Continuity Ratio = Everyone Was Enrolled for the Entire Year _______Average Member Months________ Total # of Unduplicated Enrollees that Year = Continuity Ratio
groups for the 2017-19 biennium is estimated at 62.47%
decreases from 100% in 2016 to 90% in years 2020 and beyond
– 2014 CMS guidance indicated that states would not receive the full-enhanced match rate for their Medicaid expansion population under 12-month continuous eligibility
19
SFY Year Estimated ACA Enhanced FMAP 12-Month CE FMAP for Adults FMAP Reduction 17-19 Biennium 2018 94.50% 93.68%
2019 93.50% 92.68% Table 4. Federal Participation for Oregon’s Medicaid Expansion Population with New Policy (i.e. 12-Month Continuous Eligibility), 2017-19 Biennium
20
Current Policy New Policy Change 17-19 Biennium Total Member Months of Coverage 11.8 million 13.5 million 1.7 million PMPM Cost $770 $759 N/A Federal Share FMAP $7.64 billion 83.81% $8.66 billion 83.58% $1.01 billion
State Share $1.47 billion $1.7 billion $223 million Total Program Cost 2017-19 Biennium† $9.1 billion $10.3 billion $1.2 billion
†The change in combined program expenditure from “current policy” to “new policy” reflects a change in the ratio of clients due to changes in the continuity ratio for the respective adult populations resulting from the implementation of 12-month continuous eligibility. Because each eligibility group has a different program expenditure (PMPM), the combined weighted average PMPM is different when the ratio of member months changes.
Table 8. Combined Estimated Cost for OHP Adult Populations, 2017-19 Biennium
If a 12-month continuous eligibility policy were implemented for OHP adults for the 17-19 biennium:
additional member months of coverage.
– Continuity ratios are estimated to increase on average by nearly 10 percent for the three OHP adult populations.
$1.23 billion
21
Committee’s Task:
feasibility of 12-month continuous eligibility for adults in OHP in the 2017-19 biennium.
next biennium. Potential Recommendations:
month continuous eligibility for 17-19 biennium
Request policy as part of Oregon’s 1115 Waiver renewal: Propose to the Centers for Medicare and Medicaid Services (CMS) that 12-month continuous eligibility for OHP income-eligible adults be incorporated into Oregon’s 1115 waiver in 2017, including waiving the reduction in FMAP for this policy, reducing the overall state investment to $165 million. Monitor OHP program performance: Implement data collection procedures to monitor changes in the fiscal, quality and health outcomes that result from churn in OHP: Adopt transparent OHP eligibility, enrollment and redetermination performance indicators. Complete annual assessment of administrative costs that result from churn and potential savings to the Medicaid program, CCOs, and health providers if this policy were adopted. Conduct longitudinal cost-benefit study: estimate potential financial benefits that could result from changes in health care utilization associated with increases in coverage continuity (i.e. stable Medicaid coverage).
Darren Coffman, Director Jason Gingerich, Policy Analyst Health Evidence Review Commission
26
– Diagnostic office visit(s) – Imaging/lab/biopsies
– Prescription drugs – DME and supplies – Other ancillary services
appear on list (formerly excluded services)
– Excluded in DMAP administrative rules – Cosmetic services – Experimental treatments – Not effective for any condition
1) Maternity/Newborn Care (100) 2) Primary & Secondary Prevention (95) 3) Chronic Disease Management (75) 4) Reproductive Services (70) 5) Comfort Care (65) 6) Fatal Conditions – Disease Modification/Cure (40) 7) Nonfatal Conditions – Disease Mod./Cure (20) 8) Self-limited Conditions (5) 9) Inconsequential Care (1)
27
28
29
Total Score: 3300 Line: 33
Line number (funding line is 476 for this list)
If the diagnosis and the procedure appear on the same line, the service is covered said to “Pair” (though it may be subject to a guideline note or coding specification). If the line number where it “pairs” is above the funding line, it’s covered.
Condition/treatment descriptions (plain English approximations) Reference to guideline notes
31
Funded Lines:
26 Schizophrenia 51 Appendicitis 143 Glaucoma 195 Breast cancer 288 COPD 347 Dental caries (Fillings) 358 Closed fracture of extremities 370 Strep throat 414 Migraine headaches
Unfunded Lines:
481 Chronic otitis media 519 Esophagitis and GERD (long- term medical therapy) 530 Uncomplicated hernia 545 Back pain* 567 Transplant for liver cancer 579 Uncomplicated lymphedema* 609 Sleep disorders w/o apnea 617 Common cold *Changes are scheduled for January, 2016
32
Biennial review
– Effective January 1st of even numbered years – Significant changes
Interim modifications
– Effective every January 1st and October 1st – Technical changes
33
Comorbidity rule
– Nasal allergies unfunded
CCO flexibility
– CCOs have flexibility to cover services at their discretion, but the rates they receive assume only funded services
34
Evidence-based medicine has shifted coverage decisions to rely on quality trials where possible.
list
removed existing services from list
35
between expanding eligibility vs. benefits. But budget constraints remain.
– Changes to Guideline Note 12 (Cancer treatment with little or no benefit) – Removal of age limits and other language that might be considered discriminatory
36
38
Value-based Benefits Subcommittee
Evidence-based guidelines subcommittee
Health Technology Assessment Subcommittee
Coverage Guidance Coverage Guidance
Coverage Guidance Prioritized List Changes
Topic Selection Report Development Review and Approval Monitoring
Topic Identification
41
42
– eGov Delivery notice – Public meeting information – Written and verbal comment guidelines
43
Jason Gingerich, Policy Analyst Health Evidence Review Commission (503) 373-1771 Jason.D.Gingerich@state.or.us
44
64
Library.